NTN Buzztime Announces Approval of Merger with Brooklyn Immunotherapeutics by Stockholders at Special Meeting
Buzztime Business
MARCH 15, 2021
Two proposals did not pass: (a) Proposal 4, to amend NTN’s certificate of incorporation to grant voting rights to the holders of NTN’s outstanding Series A convertible preferred stock on an as-converted to common stock basis, and (b) Proposal 6, to sell the assets relating to NTN’s historic business to eGames.com Holding LLC.
Let's personalize your content